Drug Imports From Canada Allowed to Keep Prescription Costs Down

Sept. 25, 2020, 12:24 AM UTC

The U.S. will import some medications from Canada in order to keep prescription prices down, the Food and Drug Administration announced Thursday.

The final rule allows states, tribes, pharmacists, and wholesalers to submit plans to the FDA to import medications provided they can demonstrate the moves would save patients money. Import plan sponsors must also show the medications being brought in pose no threats to patient safety.

The rule will take effect 60 days after it is published in the Federal Register.

In separate guidance, the FDA detailed requirements to import biological products. The products must be approved by ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.